Quest Diagnostics Stock Gains From New Offerings, Customer Wins

Quest Diagnostics (DGX) has been gaining from its existing solid customer relationships, new customer wins, broad health plan access and advanced diagnostics offerings. The stock carries a Zacks Rank #2 (Buy) currently. Factors Driving DGX Stock Quest Diagnostics has been experiencing robust volume growth in its core business (excluding COVID testing), banking on the growth of new physician and hospital customers, a more favorable test mix with increased use of advanced diagnostics, continued strength in he ...